Genentech, Inc.
15 drugs in NADAC|0 Generic,15 Brand
View Recalls (4)Genentech, Inc. lists 15 NDCs in the CMS NADAC file (0 generic, 15 brand), at an average NADAC of $196.52 per unit, with a week-over-week move of -0.1% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.
Total Drugs
15
0G / 15B
Avg Price / Unit
$196.5244
$2.43 – $1279.06
Avg 7d Change
-0.07%
Across 6 drugs with changes
7d Activity
of 15 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Frequently Asked Questions
How many drugs does Genentech, Inc. make?
Genentech, Inc. lists 15 NDCs in the CMS NADAC file — 0 generic and 15 brand products.
What is the average price of Genentech, Inc. drugs?
The average NADAC across Genentech, Inc.'s portfolio is $196.5244 per unit, ranging from $2.4329 to $1279.0578.
What types of drugs does Genentech, Inc. make?
Genentech, Inc. makes drugs across 5 FDA pharmacologic classes. The most common by NDC count are Antimetabolite Immunosuppressant (5), Neuraminidase Inhibitor (4), Interleukin-6 Receptor Antagonist (2), Polymerase Acidic Endonuclease Inhibitor (2), Recombinant Human Deoxyribonuclease 1 (1).
Has Genentech, Inc. had any drug recalls?
4 FDA recalls are matched to Genentech, Inc. in the openFDA feed, most recently on May 20, 2024.
How has Genentech, Inc.'s pricing changed recently?
Over the past 7 days, 0 Genentech, Inc. products rose and 6 fell, with a portfolio-wide average change of -0.1%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ACTEMRA ACTPEN 162 MG/0.9 ML tocilizumab | $1279.0578 per ML | — |
ACTEMRA 162 MG/0.9 ML SYRINGE tocilizumab | $1001.1205 per ML | — |
CATHFLO ACTIVASE 2 MG VIAL Alteplase | $186.3796 per EA | — |
XOFLUZA 80 MG TABLET BALOXAVIR MARBOXIL | $161.9683 per EA | -0.01% |
XOFLUZA 40 MG TABLET BALOXAVIR MARBOXIL | $161.9466 per EA | -0.02% |
PULMOZYME 1 MG/ML AMPUL dornase alfa | $53.1220 per ML | -0.10% |
CELLCEPT 500 MG TABLET Mycophenolate Mofetil | $17.3742 per EA | -0.08% |
CELLCEPT 500 MG TABLET Mycophenolate Mofetil | $17.3742 per EA | -0.08% |
TAMIFLU 75 MG CAPSULE oseltamivir phosphate | $14.5186 per EA | — |
TAMIFLU 45 MG CAPSULE oseltamivir phosphate | $13.5402 per EA | — |
TAMIFLU 30 MG CAPSULE oseltamivir phosphate | $13.3994 per EA | — |
CELLCEPT 250 MG CAPSULE Mycophenolate Mofetil | $8.6490 per EA | — |
CELLCEPT 250 MG CAPSULE Mycophenolate Mofetil | $8.6490 per EA | — |
CELLCEPT 200 MG/ML ORAL SUSP Mycophenolate Mofetil | $8.3330 per ML | -0.15% |
TAMIFLU 6 MG/ML SUSPENSION Oseltamivir Phosphate | $2.4329 per ML | — |
FDA Recalls (4)
Recalls matched by company name. Verify current status with FDA.
Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San Francisco, CA 94080, NDC 50242-041-64
Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase.
Klonopin (clonazepam) 0.5 mg Tablets,100-count bottle, Rx only. Made in Canada, Distributed by Genentech USA, Inc. A Member of the Roach Group, 1 DNA Way South San Francisco, CA 94080-4990. NDC 0004-0068-01
Labeling: Not Elsewhere Classified: Schedule IV controlled substance indicator of CIV being omitted from the product carton, primary label is correct.
Activase (alteplase), 100 mg (58 million IU), Lyophilized vial, packaged with 1 single-dose 100ml vial of sterile water for Injection USP and one transfer device. Manufactured by: Genentech, Inc. 1 DNA Way, South San Francisco, CA 84080-4990. NDC: 50242-0085-27
Non-Sterility:presence of cracked or chipped glass at the neck of Sterile Water for Injection vials.
CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, NDC 0004-0259-05; b) 120-count capsules per bottle, NDC 0004-0259-51; Made in Ireland; Distributed by: Genentech USA, Inc., South San Francisco, CA 94080.
Short Fill: some bottles contained less than 120-count per labeled claim.